Investigation into Tandem Diabetes Care Securities Claims

Tandem Diabetes Care, Inc. is under investigation for allegedly issuing misleading business information to the public, potentially affecting the value of its securities. Shareholders who purchased the company's stocks may be entitled to compensation through a class action lawsuit.

Key Takeaways:

• The Rosen Law Firm is investigating potential securities claims on behalf of Tandem Diabetes Care shareholders, alleging that the company may have issued misleading business information to the investing public.
• The investigation follows the company's press release on August 7, 2025, announcing a voluntary medical device correction for select t:slim X2 insulin pumps, which resulted in a 19.9% drop in Tandem Diabetes' stock.
• The Rosen Law Firm has a successful track record in securities class actions, having achieved the largest ever securities class action settlement against a Chinese company at the time and securing over $438 million for investors in 2019.
• The firm has been ranked in the top 4 for number of securities class action settlements since 2013 and has recovered hundreds of millions of dollars for investors.
• Investors who purchased Tandem Diabetes Care securities may be entitled to compensation without paying out-of-pocket fees or costs through a contingency fee arrangement with the Rosen Law Firm.
• To join the prospective class action, investors can visit the Rosen Law Firm's website or call Phillip Kim, Esq., toll-free at 866-767-3653.

Statistics:

• 19.9%: The percentage drop in Tandem Diabetes' stock on August 7, 2025, following the company's press release announcing a voluntary medical device correction for select t:slim X2 insulin pumps.
• $438 million: The amount secured by the Rosen Law Firm for investors in 2019 through securities class action settlements.
• 2013: The year the Rosen Law Firm was initially ranked in the top 4 for number of securities class action settlements, a ranking it has maintained annually since then.
• $100 million+: The amount recovered by the Rosen Law Firm for investors through securities class actions since 2013.

Sources:

• Rosen Law Firm press release, "Investigation into Tandem Diabetes Care Securities Claims"
• SEC filing, "Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps"
• Law360 article, "Laurence Rosen Named Titan Of Plaintiffs' Bar"
• ISS Securities Class Action Services rankings, 2013-2019
• Rosen Law Firm's website and social media channels.